Overview
We are focused on leveraging core expertise in drug discovery and development and kinase inhibition to develop novel, small molecule therapies to help people impacted by under served immuno-inflammatory conditions. Our team of experienced and accomplished kinome experts use the proprietary KINect® technology platform to generate clinical candidates for difficult to drug kinases with novel approaches. The ability to systemically and efficiently attach human kinases with adenosine triphosphate (ATP) site cysteines (the human cysteinome) differentiates Raspberry from competitors.
- Infectious Diseases & Vaccines
- Immunology
- Cardiovascular & Metabolism
- Neuroscience
- Oncology
- Pulmonary Hypertension
“There are still many diseases for which there is no cure, and effective drugs must be found. Although we have contributed to the solutions for some of these problems, we will continue our research efforts, because so much more needs to be done.”
